Late last month, Boston Scientific announced it was pausing a study examining pulsed field ablation as a first-line therapy.
Boston Scientific temporarily paused enrolment in its AVANT GUARD trial in October to “assess a few unanticipated ...
As Boston Scientific’s pulsed field ablation business continues to grow, the medtech aims to nourish the program with the ...
The technology is integrated with company’s electroanatomical mapping system, which helps guide operators during AF ablation.
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ ...
Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ...
Boston Scientific expects to complete enrollment in the coming months in the study comparing pulsed field ablation to ...
The VARIPULSE™ Platform is the first and only Pulsed Field Ablation (PFA) System in the U.S. fully integrated with the CARTO™ 3 Electro-anatomical Mapping System, driving efficiency ...
Johnson & Johnson MedTech today announced the completed enrollment of the pilot phase of a clinical trial for its Omnypulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback